HISTOMORPHOMETRIC EFFECT OF 6-MONTH TREATMENT WITH ORAL RISEDRONATE IN PATIENTS WITH MULTIPLE-MYELOMA

被引:9
作者
COHENSOLAL, ME
ROUX, C
VALENTINOPRAN, A
DOUGADOS, M
AMOR, B
DEVERNEJOUL, MC
机构
[1] PROCTER & GAMBLE PHARMACEUT, EGHAM, ENGLAND
[2] HOP COCHIN, DEPT RHUMATOL, F-75674 PARIS 14, FRANCE
关键词
D O I
10.1016/8756-3282(93)90187-F
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:505 / 509
页数:5
相关论文
共 9 条
[1]
EFFECT OF DAILY ETIDRONATE ON THE OSTEOLYSIS OF MULTIPLE-MYELOMA [J].
BELCH, AR ;
BERGSAGEL, DE ;
WILSON, K ;
OREILLY, S ;
WILSON, J ;
SUTTON, D ;
PATER, J ;
JOHNSTON, D ;
ZEE, B .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1397-1402
[2]
DECREASED BONE-FORMATION IN OSTEOPOROTIC PATIENTS COMPARED WITH AGE-MATCHED CONTROLS [J].
CARASCO, MG ;
DEVERNEJOUL, MC ;
STERKERS, Y ;
MORIEUX, C ;
KUNTZ, D ;
MIRAVET, L .
CALCIFIED TISSUE INTERNATIONAL, 1989, 44 (03) :173-175
[3]
COHENSOLAL M, 1991, J BONE MINER RES, V6, P915
[4]
LONG-TERM EFFECTS OF DICHLOROMETHYLENE DIPHOSPHONATE (CL2MDP) ON SKELETAL LESIONS IN MULTIPLE-MYELOMA [J].
DELMAS, PD ;
CHARHON, S ;
CHAPUY, MC ;
VIGNON, E ;
BRIANCON, D ;
EDOUARD, C ;
MEUNIER, PJ .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1982, 4 (03) :163-168
[5]
DOUGLAS DL, 1980, LANCET, V1, P1043
[6]
Fleisch H, 1987, BONE S1, V8, P523
[7]
MARCELLI C, 1988, CANCER-AM CANCER SOC, V62, P1163, DOI 10.1002/1097-0142(19880915)62:6<1163::AID-CNCR2820620620>3.0.CO
[8]
2-6
[9]
QUANTITATIVE HISTOLOGY OF MYELOMA-INDUCED BONE CHANGES [J].
VALENTINOPRAN, A ;
CHARHON, SA ;
MEUNIER, PJ ;
EDOUARD, CM ;
ARLOT, ME .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 52 (04) :601-610